[Class I cytokines (interleukin-2-7, interleukin-9, interleukin-11, interleukin-12, interleukin-13, interleukin-15, granulocyte-macrophage colony-stimulating factor, granulocyte-colony stimulating factor, erythropoietin)].
Yokota
Takashi
T
Division of Stem Cell Biology, Department of Cancer Medicine, Graduate School of Medical Science, Kanazawa University.
D000740:Anemia / Q000188:drug therapy; D000818:Animals; D016207:Cytokines / Q000145:classification* / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D015316:Genetic Therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000628:therapy; D009503:Neutropenia / Q000188:drug therapy; D018121:Receptors, Cytokine / Q000145:classification* / Q000502:physiology*; D011994:Recombinant Proteins; D015398:Signal Transduction / Q000235:genetics* / Q000502:physiology
D016207:Cytokines; D018121:Receptors, Cytokine; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor